Thursday, November 8, 2012
Publication and contact
Rat studies suggest
antagonizing IL-1 receptor in the brain could help prevent postoperative
cognitive dysfunction in older individuals. In aged rats subjected to a
laparotomy, brain infusion of an IL-1 receptor antagonist at the time of
surgery prevented postoperative cognitive deficits and neuroinflammation,
whereas intraperitoneal injection of the same antagonist did not. Next steps
could include developing a strategy capable of delivering an IL-1 receptor
antagonist into the CNS.
an IL-1 receptor antagonist from Amgen
Inc. and Swedish
Orphan Biovitrum AB, is marketed to treat rheumatoid
a recombinant protein with the heterodimeric IL-1 receptor linked to the Fc
portion of human IgG from Regeneron
Pharmaceuticals Inc., is marketed to treat NLR family
pyrin domain containing 3 (NLRP3;
periodic syndrome (CAPS).
At least four other companies have IL-1 receptor inhibitors in Phase II
testing or earlier to treat various indications.
Published online Nov. 8, 2012
Patent and licensing status
R.M. et al. J. Neurosci.; published online Oct. 17, 2012;
Contact: Ruth M. Barrientos, University of Colorado at Boulder,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]